Breathtec Biomedical said today it tapped DTG Partners Consultants to aid the company move towards product commercialization.
DTG Partners provides product development and regulatory strategies for design, testing and manufacturing phases of medical device development, Breathtec said.
“The product development expertise Val and Rick bring to the table is critical at this stage of our development cycle. I’m happy to have them as part of our Team and really looking forward to working with both of them. We are very pleased to announce this engagement at this key juncture in the company’s growth as it reaffirms to our partners, stakeholders and shareholders alike a tangible and positive message that we are committed to delivering on our strategic timelines and goals for success,” Breathtec CEO Guy LaTorre said in a prepared statement.
The company said that DTG also provides services including identification and optimization of manufacturing technologies, selection and validation of suppliers and management of required non-clinical studies.
“We are excited by the opportunity to work with Breathtec on their cutting edge technology. We are committed to contributing our expertise towards bringing their diagnostic products through development to commercial release as quickly and efficiently as possible,” DTG Partner Val Rubinchik said in a press release.